Origa Raffaella, Galanello Renzo
Unitá di Ricerca Clinica Fase 1 srl-A.O. G.Brotzu-Cagliari, Italy.
Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:263-70.
In beta thalassemia, unbalanced alpha globin chain synthesis results in severely rheologically compromised erythrocytes with premature destruction in the peripheral circulation and ineffective erythropoiesis within the bone marrow and in extramedullary sites. In nontransfused beta thalassemia patients, erythropoiesis,anemia and hypoxia down-regulate hepcidin, the master regulator of iron homeostasis. Hepcidin deficiency in turn allows excessive duodenal iron absorption and development of systemic iron overload. In regularly transfused patients iron overload is mostly due to red cell breakdown. When the iron binding capacity of transferrin is saturated, iron can appear in the serum in a free form, called Non-Transferrin-Bound Iron, a powerful catalyst for the formation of free radicals, capable of causing oxidative stress and damage to mitochondria, lysosomes, lipid membranes, proteins, and DNA. Apart from the iron overload-related complications, other pathological conditions such as bone disease, gallstones and thromboembolic events occur in a relevant proportion of subjects with thalassemia.
在β地中海贫血中,α珠蛋白链合成失衡导致红细胞严重的流变学特性受损,使其在外周循环中过早破坏,并在骨髓和髓外部位出现无效造血。在未接受输血的β地中海贫血患者中,红细胞生成、贫血和缺氧会下调铁调素,而铁调素是铁稳态的主要调节因子。铁调素缺乏反过来又会导致十二指肠铁吸收过多和全身性铁过载的发生。在定期输血的患者中,铁过载主要是由于红细胞分解。当转铁蛋白的铁结合能力饱和时,铁可以以游离形式出现在血清中,称为非转铁蛋白结合铁,它是一种强大的自由基形成催化剂,能够引起氧化应激并损害线粒体、溶酶体、脂质膜、蛋白质和DNA。除了与铁过载相关的并发症外,其他病理状况如骨病、胆结石和血栓栓塞事件也在相当比例的地中海贫血患者中出现。